Mallinckrodt Completes Acquisition Of Therakos, Inc.
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/2/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
- GoPro to merge with Starman Optical in $285M recapitalization deal
- GoPro (GPRO) Halted, News Pending
- Crude Inventory Fell 4.5M Barrels Last Week - EIA
- Wall Street ends lower as higher yields, rising oil prices mark shaky start to September
- TScan cuts 75% of workforce, pivots to solid tumor cell therapy
Mallinckrodt (MNK) Completes $1.33B Acquisition of Therakos
September 28, 2015 6:50 AM EDTMallinckrodt (NYSE: MNK) announced that it has completed its acquisition of Therakos, Inc., from The Gores Group at a purchase price of approximately $1.325 billion. The Therakos acquisition further broadens Mallinckrodt's footprint in hospitals expanding its reach into immunotherapy through extracorporeal photopheresis (ECP) and extending the company's presence from multimodal surgical pain management and critical care respiratory therapies in... More
